-
1
-
-
0025079192
-
The tumor-inhibiting effect of diethylstiloestrol and its diphosphate on the Nb-H and NB-R prostatic carcinomas of the rat
-
Schneider MR, Human A, Graf AH. The tumor-inhibiting effect of diethylstiloestrol and its diphosphate on the Nb-H and NB-R prostatic carcinomas of the rat. J Cancer Res Clin One 1990; 116(2): 159-167.
-
(1990)
J Cancer Res Clin One
, vol.116
, Issue.2
, pp. 159-167
-
-
Schneider, M.R.1
Human, A.2
Graf, A.H.3
-
2
-
-
3142562047
-
Phase I-II trial with high dose fosfestrol in hormone-resistant adenocarcinoma of the prostate
-
Murphy G et al (eds). Paris: F115
-
Droz JP et al. Phase I-II trial with high dose fosfestrol in hormone-resistant adenocarcinoma of the prostate. In: Murphy G et al (eds). Recent Advances in Urological Cancers, Diagnosis and Treatment. Paris: F115, 1990, pp 90-91.
-
(1990)
Recent Advances in Urological Cancers, Diagnosis and Treatment
, pp. 90-91
-
-
Droz, J.P.1
-
3
-
-
0015273704
-
Renal insufficiency caused by 'silent' prostate cancer, successfully treated by diethyldioxystilbene (Honvan) and temporary haemodialysis
-
Dekema H, Oomen H. Renal insufficiency caused by 'silent' prostate cancer, successfully treated by diethyldioxystilbene (Honvan) and temporary haemodialysis. Folia Medica Neerlandica 1972; 15(3): 161-166.
-
(1972)
Folia Medica Neerlandica
, vol.15
, Issue.3
, pp. 161-166
-
-
Dekema, H.1
Oomen, H.2
-
4
-
-
0027417993
-
High dose continuous-infusion fosfestrol in hormone resistant prostate cancer
-
Droz JP et al. High dose continuous-infusion fosfestrol in hormone resistant prostate cancer. Cancer 1993; 71(Supp 3): 1123-1130.
-
(1993)
Cancer
, vol.71
, Issue.3 SUPPL.
, pp. 1123-1130
-
-
Droz, J.P.1
-
5
-
-
0024263403
-
Cardiovascular follow-up of patients with prostatic cancer treated with single drug polyestradiol phosphate
-
Henriksson P et al. Cardiovascular follow-up of patients with prostatic cancer treated with single drug polyestradiol phosphate. Prostate 1988; 13(3): 257-261.
-
(1988)
Prostate
, vol.13
, Issue.3
, pp. 257-261
-
-
Henriksson, P.1
-
6
-
-
0024541878
-
Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer
-
Henriksson P, Edhag O, Eriksson A, Johanssen SE. Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer. Br J Urol 1989; 63: 186-190.
-
(1989)
Br J Urol
, vol.63
, pp. 186-190
-
-
Henriksson, P.1
Edhag, O.2
Eriksson, A.3
Johanssen, S.E.4
-
7
-
-
0023752143
-
New results on the pharmacokinetics of fosfestrol
-
Oelschlöger H, Rottley D, Dunzendorfer U. New results on the pharmacokinetics of fosfestrol. Urol Int 1988; 43(Supp 1): 15-21.
-
(1988)
Urol Int
, vol.43
, Issue.1 SUPPL.
, pp. 15-21
-
-
Oelschlöger, H.1
Rottley, D.2
Dunzendorfer, U.3
-
8
-
-
0023690923
-
Effect of stilboestrol and testosterone on the incorporation of 75 selenomethionine by prostatic cancer cells
-
Ferro MA, Heinemann D, Smith PJ, Symes NO. Effect of stilboestrol and testosterone on the incorporation of 75 selenomethionine by prostatic cancer cells. Br J Urol 1988; 62(2): 166-172.
-
(1988)
Br J Urol
, vol.62
, Issue.2
, pp. 166-172
-
-
Ferro, M.A.1
Heinemann, D.2
Smith, P.J.3
Symes, N.O.4
-
9
-
-
0024428990
-
High-dose intravenous estrogen therapy in advanced prostatic carcinoma: Use of serum prostate specific antigen to monitor response
-
Ferro MA, Gillatt D, Symes MO, Smith EJB. High-dose intravenous estrogen therapy in advanced prostatic carcinoma: Use of serum prostate specific antigen to monitor response. Urology 1989; 34: 134-138.
-
(1989)
Urology
, vol.34
, pp. 134-138
-
-
Ferro, M.A.1
Gillatt, D.2
Symes, M.O.3
Smith, E.J.B.4
-
10
-
-
0021840733
-
A phase II study of high-dose estrogens (diethylstilboestrol diphosphate) in prostate cancer
-
Cetrin DL et al. A phase II study of high-dose estrogens (diethylstilboestrol diphosphate) in prostate cancer. Cancer 1985; 56: 457-460.
-
(1985)
Cancer
, vol.56
, pp. 457-460
-
-
Cetrin, D.L.1
|
